Publications by authors named "Celestine Simand"

Claim this Profile
D
Dexamethasone added to induction and post-remission therapy in older patients with newly diagnosed acute myeloid leukemia: a multicenter, phase II trial (DEXAML-02).
Sarah Bertoli, Emilie Bérard, Pierre Peterlin, Romain Guieze, Yohan Desbrosses, Célestine Simand

Haematologica· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pivotal results of SELECT-MDS-1 phase 3 study of tamibarotene with azacitidine in newly diagnosed higher-risk MDS.
Amy E DeZern, Sylvain Thepot, Stephane de Botton, Andrea Patriarca, Dries Deeren, Célestine Simand

Blood Adv· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intermediate-Dose Cytarabine as Postinduction AML Therapy.
Mathilde Hunault, Cécile Pautas, Sarah Bertoli, Pierre-Yves Dumas, Emmanuel Raffoux, Célestine Simand

NEJM Evid· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and tolerance of brexucabtagene autoleucel in adults with R/R B-ALL: a GRAALL study from the DESCAR-T registry.
Florence Rabian, David Beauvais, Tony Marchand, Sabine Fürst, Anne Huynh, Célestine Simand

Blood Adv· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of acute myeloid leukemia patients who responded to venetoclax and azacitidine and stopped treatment.
Sylvain Garciaz, Pierre-Yves Dumas, Sarah Bertoli, David A Sallman, Justine Decroocq, Celestine Simand

Am J Hematol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transient red blood cell agglutination after Magrolimab administration in acute myeloid leukemia.
Antoine Leveque, Delphine Rolland, Marie-Pierre Ledoux, Célestine Simand, Alice Eischen

Int J Lab Hematol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IDALLO study: A retrospective multicenter study of the SFGM-TC evaluating the efficacy and safety of ivosidenib in relapsed IDH1-mutated AML after allogeneic hematopoietic cell transplantation.
Adrien Caillet, Marion Simonet-Boissard, Edouard Forcade, Marie Robin, Marie-Thérèse Rubio, Célestine Simand

Hemasphere· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bone marrow graft versus peripheral blood graft in haploidentical hematopoietic stem cells transplantation: a retrospective analysis in1344 patients of SFGM-TC registry.
Claire Lacan, Jérôme Lambert, Edouard Forcade, Marie Robin, Patrice Chevallier, Célestine Simand

J Hematol Oncol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world clinical outcome of cefiderocol for treatment of multidrug-resistant non-fermenting, gram negative bacilli infections: a case series.
Baptiste Hoellinger, Célestine Simand, Katy Jeannot, Carlos Garijo, Mircea Cristinar

Clin Microbiol Infect· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retrospective, real-life study of venetoclax plus azacitidine or low-dose cytarabine in French patients with acute myeloid leukemia ineligible for intensive chemotherapy.
Louise Laloi, Natacha Chaumard Billotey, Pierre-Yves Dumas, Franciane Paul, Alban Villate, Célestine Simand

Cancer Med· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combining blinatumomab and donor lymphocyte infusion in B-ALL patients relapsing after allogeneic hematopoietic cell transplantation: a study of the SFGM-TC.
Paul Chauvet, Annalisa Paviglianiti, Myriam Labopin, Hélène Labussière, Nicolas Boissel, Célestine Simand

Bone Marrow Transplant· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapy-related Myeloid Neoplasms Following PARP Inhibitors: Real-life Experience.
Vincent Marmouset, Justine Decroocq, Sylvain Garciaz, Gabriel Etienne, Amine Belhabri, Célestine Simand

Clin Cancer Res· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of HLA-mismatched unrelated donor transplantation with post-transplant cyclophosphamide versus HLA-haploidentical transplantation in patients with active acute myeloid leukemia.
Frédéric Baron, Myriam Labopin, Johanna Tischer, Fabio Ciceri, Anna Maria Raiola, Celestine Simand

Bone Marrow Transplant· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Comparison of HLA-mismatched unrelated donor transplantation with post-transplant cyclophosphamide versus HLA-haploidentical transplantation in patients with active acute myeloid leukemia.
Frédéric Baron, Myriam Labopin, Johanna Tischer, Fabio Ciceri, Anna Maria Raiola, Celestine Simand

Bone Marrow Transplant· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of Short- and Long-Term Mortality in Patients with or without Cancer Admitted to the ICU for Septic Shock: A Retrospective Observational Study.
Pierrick Le Borgne, Léa Feuillassier, Maleka Schenck, Jean-Etienne Herbrecht, Ralf Janssen-Langenstein, Celestine Simand

Cancers (Basel)· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Poly(ADP-ribose)polymerase inhibitors-associated myeloid neoplasms: a retrospective study from the French Network of Pharmacovigilance centres.
Pierre-Marie Morice, Alexis Genthon, Thomas Boyer, Kevin Bihan, Julien Mahé, Célestine Simand

Br J Haematol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
On Behalf of the SFGM-TC: Retrospective Comparison of Reduced and Higher Intensity Conditioning for High-Risk Myelodysplastic Syndrome Treated With Allogeneic Stem-Cell Transplantation.
Arnaud Campidelli, Marie Robin, Thomas Remen, Amandine Luc, Hélène Labussière-Wallet, Célestine Simand

Clin Lymphoma Myeloma Leuk· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ikaros deficiency is associated with aggressive BCR-ABL1 B-cell precursor acute lymphoblastic leukemia independent of the lineage and developmental origin.
Célestine Simand, Céline Keime, Aurélie Cayé, Chloé Arfeuille, Marie Passet

Haematologica· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors associated with coinfections in invasive aspergillosis: a retrospective cohort study.
François Danion, Céline Duval, François Séverac, Philippe Bachellier, Ermanno Candolfi, Célestine Simand

Clin Microbiol Infect· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unusual presentation of toxoplasmosis with gastro-intestinal involvement in HLA non-identical stem cell transplantation.
Baptiste Hoellinger, Axel Ursenbach, Odile Villard, Blandine Guffroy, Célestine Simand

Transpl Infect Dis· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular classification and prognosis in younger adults with acute myeloid leukemia and intermediate-risk cytogenetics treated or not by gemtuzumab ozogamycin: Final results of the GOELAMS/FILO acute myeloid leukemia 2006-intermediate-risk trial.
Anne Bouvier, Jean-François Hamel, Jacques Delaunay, Eric Delabesse, Pierre-Yves Dumas, Célestine Simand

Eur J Haematol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility and Outcomes of a Third Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Andreas Rank, Christophe Peczynski, Myriam Labopin, Matthias Stelljes, Celestine Simand

Transplant Cell Ther· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blinatumomab + ponatinib for relapsed/refractory Philadelphia chromosome-positive acute lymphoblastic leukemia in adults.
Marie-Anne Couturier, Xavier Thomas, Emmanuel Raffoux, Françoise Huguet, Céline Berthon, Célestine Simand

Leuk Lymphoma· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ikaros antagonizes DNA binding by STAT5 in pre-B cells.
Beate Heizmann, Stéphanie Le Gras, Célestine Simand, Patricia Marchal, Susan Chan

PLoS One· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Ikaros antagonizes DNA binding by STAT5 in pre-B cells.
Beate Heizmann, Stéphanie Le Gras, Célestine Simand, Patricia Marchal, Susan Chan

PLoS One· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis